troponin testing
Top Five Articles on 360Dx Last Week: Labcorp's Stake in European Firm; POC Testing Adoption; More
Last week, readers were most interested in a story about Labcorp's $190 million stake in SYNLAB, and its $2 billion public offering of senior notes.
POC High-Sensitivity Troponin Tests Could Reduce ER Overcrowding. Is That Enough for Adoption?
Premium
Several firms are bringing high-sensitivity cardiac troponin testing into the ER, although doctors are not yet certain how much difference the tests will make.
QuidelOrtho Recalls Triage Cardiac Panels Due to False Negative Results
The FDA has identified this as a Class I recall, the most serious type of recall, as use of these devices may cause serious injury or death.
Although there is still demand for the company's COVID-19 products, it has also launched tests for cardiovascular disease, Alzheimer's, and more.
The company, which received CE marking for its high sensitivity troponin I assay and Atellica VTLi Patient-side Immunoassay Analyzer, plans to enter the US market.